Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

被引:654
作者
Kim, Donghee [1 ,2 ]
Kim, W. Ray [1 ]
Kim, Hwa Jung [3 ]
Therneau, Terry M. [4 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Seoul Natl Univ Hosp, Dept Internal Med, Inst Healthcare Res, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea
[3] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Seoul, South Korea
[4] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN 55905 USA
关键词
POPULATION-BASED COHORT; TERM-FOLLOW-UP; NATURAL-HISTORY; RISK; NAFLD; STEATOHEPATITIS; EPIDEMIOLOGY; PREVALENCE; PREDICT; SYSTEM;
D O I
10.1002/hep.26156
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The clinical and public health significance of nonalcoholic fatty liver disease (NAFLD) is not well established. We investigated the long-term effect of NAFLD on mortality. This analysis utilized the National Health and Nutrition Examination Survey conducted in 1988-1994 and subsequent follow-up data for mortality through December 31, 2006. NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other known liver diseases. The presence and severity of hepatic fibrosis in subjects with NAFLD was determined by the NAFLD fibrosis score (NFS), the aspartate aminotransferase to platelet ratio index (APRI), and FIB-4 score. Of 11,154 participants, 34.0% had NAFLDthe majority (71.7%) had NFS consistent with lack of significant fibrosis (NFS <1.455), whereas 3.2% had a score indicative of advanced fibrosis (NFS >0.676). After a median follow-up of 14.5 years, NAFLD was not associated with higher mortality (age- and sex-adjusted hazard ratio [HR]: 1.05; 95% confidence interval [CI]: 0.93-1.19). In contrast, there was a progressive increase in mortality with advancing fibrosis scores. Compared to subjects without fibrosis, those with a high probability of advanced fibrosis had a 69% increase in mortality (for NFS: HR, 1.69, 95% CI: 1.09-2.63; for APRI: HR, 1.85, 95% CI: 1.02-3.37; for FIB-4: HR, 1.66, 95% CI: 0.98-2.82) after adjustment for other known predictors of mortality. These increases in mortality were almost entirely from cardiovascular causes (for NFS: HR, 3.46, 95% CI: 1.91-6.25; for APRI: HR, 2.53, 95% CI: 1.33-4.83; for FIB-4: HR, 2.68, 95% CI: 1.44-4.99). Conclusions: Ultrasonography-diagnosed NAFLD is not associated with increased mortality. However, advanced fibrosis, as determined by noninvasive fibrosis marker panels, is a significant predictor of mortality, mainly from cardiovascular causes, independent of other known factors. (HEPATOLOGY 2013)
引用
收藏
页码:1357 / 1365
页数:9
相关论文
共 38 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].
Adams, LA ;
Sanderson, S ;
Lindor, KD ;
Angulo, P .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138
[3]   GI Epidemiology: nonalcoholic fatty liver disease [J].
Angulo, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (08) :883-889
[4]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[5]   Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance? [J].
Angulo, Paul .
HEPATOLOGY, 2010, 51 (02) :373-375
[6]  
[Anonymous], 1994, Vital Health Stat 2, P1
[7]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[8]   Comparison of blood tests for liver fibrosis specific or not to NAFLD [J].
Cales, Paul ;
Laine, Fabrice ;
Boursier, Jerome ;
Deugnier, Yves ;
Moal, Valerie ;
Oberti, Frederic ;
Hunault, Gilles ;
Rousselet, Marie Christine ;
Hubert, Isabelle ;
Laafi, Jihane ;
Ducluzeaux, Pierre Henri ;
Lunel, Francoise .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :165-173
[9]   The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023
[10]   The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans [J].
Choi, Su-Yeon ;
Kim, Donghee ;
Kim, Hwa Jung ;
Kang, Jin Hwa ;
Chung, Su Jin ;
Park, Min Jung ;
Kim, Young Sun ;
Kim, Chung Hyun ;
Choi, Seung Ho ;
Kim, Won ;
Kim, Yoon Jun ;
Yoon, Jung-Hwan ;
Lee, Hyo-Suk ;
Cho, Sang-Heon ;
Sung, Myung-Whun ;
Oh, Byung-Hee .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (08) :1953-1960